Factor v leiden and antiphospholipid antibodies in either mothers or infants increase the risk for perinatal arterial ischemic stroke

Stroke

Volumn 40, Issue 1, 2009, Pages 65-70

  Simchen, Michal J ^a   Goldstein, Gal ^a   Lubetsky, Aaron ^a   Strauss, Tzipi ^a   Schiff, Eyal ^a   Kenet, Gili ^a  

^a SHEBA MEDICAL CENTER   (Israel)

Author keywords

Antiphospholipid antibodies; FVL; Perinatal ischemic stroke; Thrombophilia

Indexed keywords

ANTITHROMBIN; BLOOD CLOTTING FACTOR 5 LEIDEN; BLOOD CLOTTING FACTOR 8; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); PHOSPHOLIPID ANTIBODY; PROTEIN C; PROTEIN S; AUTOANTIBODY; BIOLOGICAL MARKER; BLOOD CLOTTING FACTOR 5; PHOSPHOLIPID;

ADOLESCENT; ADULT; ARTERIAL ISCHEMIC STROKE; ARTICLE; CEREBROVASCULAR ACCIDENT; CHILD; CONTROLLED STUDY; DISEASE PREDISPOSITION; DNA POLYMORPHISM; FEMALE; GENE MUTATION; HUMAN; INFANT; MAJOR CLINICAL STUDY; NEWBORN; PERINATAL MORBIDITY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN C DEFICIENCY; RISK FACTOR; SCHOOL CHILD; THROMBOPHILIA; BLOOD; BRAIN ARTERY; BRAIN ISCHEMIA; COHORT ANALYSIS; FETOMATERNAL TRANSFUSION; GENETIC MARKER; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; MALE; MUTATION; PATHOLOGY; PATHOPHYSIOLOGY; PREGNANCY; PROSPECTIVE STUDY; STROKE;

ADOLESCENT; AUTOANTIBODIES; BIOLOGICAL MARKERS; BRAIN ISCHEMIA; CEREBRAL ARTERIES; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FACTOR V; FEMALE; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MATERNAL-FETAL EXCHANGE; MUTATION; PHOSPHOLIPIDS; PREGNANCY; PROSPECTIVE STUDIES; RISK FACTORS; STROKE; THROMBOPHILIA;

EID: 60549113538     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.108.527283     Document Type: Article

References (40)

1. Nelson KB. Perinatal ischemic stroke. Stroke. 2007;38:742-745.
2. Lynch JK, Nelson KB. Epidemiology of perinatal stroke. Curr Opin Pediatr. 2001;13:499-505.
3. Chalmers EA. Perinatal stroke - risk factors and management. Br J Haematol. 2005;130:333-343.
4. Laugesaar R, Kolk A, Tomberg T, Metsvaht T, Lintrop M, Varendi H, Talvik T. Acutely and retrospectively diagnosed perinatal stroke: a population-based study. Stroke. 2007;38:2234-2240.
5. Schulzke S, Weber P, Luetschg J, Fahnenstich H. Incidence and diagnosis of unilateral arterial cerebral infarction in newborn infants. J Perinat Med. 2005;33:170-175.
6. Golomb MR, MacGregor DL, Domi T, Armstrong DC, McCrindle BW, Mayank S, de Veber GA. Presumed pre- or perinatal arterial ischemic stroke: risk factors and outcomes. Ann Neurol. 2001;50:163-168.
7. Sreenan C, Bhargava R, Robertson CM. Cerebral infarction in the term newborn: clinical presentation and long-term outcome. J Pediatr. 2000; 137:351-355.
8. Wu YW, March WM, Croen LA, Grether JK, Escobar GJ, Newman TB. Perinatal stroke in children with motor impairment: a population-based study. Pediatrics. 2004;114:612.- 619.
9. Golomb MR, Garg BP, Saha C, Azzouz F, Williams LS. Cerebral Palsy after perinatal ischemic stroke. J Child Neurol. 2008;23:279-286.
10. Fitgerald KC, Williams LS, Garg BP, Golomb MR. Epilepsy in children with delayed presentation of perinatal stroke. J Child Neurol. 2007;22: 1274-1280.
11. Wu YW, Escobar GJ, Grether JK, Croen LA, Greene JD, Newman TB. Chorioamnionitis and cerebral palsy in term and near-term infants. JAMA. 2003;290:2677-2684.
12. Lee J, Croen LA, Backstrand KH, Yoshida CK, Henning LH, Lindan C, Ferriero DM, Fullerton HJ, Barkovich AJ, Wu YW. Maternal and infant characteristics associated with perinatal arterial stroke in the infant. JAMA. 2005;293:723-729.
13. de Veber G, Andrew M, Adams C, Bjornson B, Booth F, Buckley DJ, Camfield CS, David M, Humphreys P, Langevin P, MacDonald EA, Gillett J, Meaney B, Shevell M, Sincleair DB, Yager J. Canadian Pediatric Ischemic Stroke Study Group. Cerebral sinovenous thrombosis in children. N Engl J Med. 2001;345:417-423.
14. Gunther G, Junker R, Strater R, Schobess R, Kurnik K, Heller C, Kosch A, Nowak-Gottl U, Childhood Stroke Study Group. Symptomatic ischemic stroke in full-term neonates: role of acquired and genetic prothrombotic risk factors. Stroke. 2000;31:2437-2441.
15. Golomb MR. The contribution of prothrombotic disorders to peri- and neonatal ischemic stroke. Semin Thromb Hemost. 2003;29:415-424.
16. Miller SP, Wu YW, Lee J, Lammer EJ, Iovannisci DM, Glidden DV, Bonifacio SL, Collins A, Shaw GM, Barkovich AJ, Ferriero DM. Candidate gene polymorphisms do not differ between newborns with stroke and normal controls. Stroke. 2006;37:2678-2683.
17. Salomon O, Seligsohn U, Steinberg DM, Zalel Y, Lerner A, Rosenberg N, Pshithizki M, Oren M, Ravid B, Davidson J, Schiff E, Achiron R. The common prothrombotic factors in nulliparous women do not compromise blood flow in the feto-maternal circulation and are not associated with preeclampsia or intrauterine growth restriction. Am J Obstet Gynecol. 2004;191:2002-2009.
18. Paidas MJ, Ku DH, Arkel YS. Screening and management of inherited thrombophilias in the setting of adverse pregnancy outcome. Clin Perinatol. 2004;31:783-805.
19. Alfirevic Z, Roberts D, Martlew V. How strong in the association between maternal thrombophilia and adverse pregnancy outcome? a systematic review. Eur J Obstet Gynecol Rep Biol. 2002;101:6-14.
20. Rey E, Kahn SR, David D, Shrier I. Thrombophilic disorders and fetal loss: a meta-analysis. Lancet. 2003;361:901-908.
21. Alfirevic Z, mousa HA, Martlew V, Brisco L, Perez-Casal M, Hock Toh C. Postnatal screening for thrombophilia in women with severe pregnancy complications. Obstet Gynecol. 2001;97:753-759.
22. Cowan F, Rutherford M, Groenendaal F, Eken P, Mercuri E, Bydder GM, Meiners LC, Dubowitz LM, de Veries LS. Origin and timing of brain lesions in term infants with neonatal encephalopathy. Lancet. 2003;361: 736-742.
23. Cawan F, DeVries LS. The internal capsule in neonatal imaging. Semin Fetal Neonatal Med. 2005;10:461-474.
24. Kenet G, Waldman D, Lubetsky A, Kornbrut N, Chalil A, Koren A, Wolach B, Fattal A, Kapelushnik Y, Tamary H, Yacobovitch J, Raveh E, Revel-Vilk S, Toren A, Brenner B. Pediatric cerebral sinus vein thrombosis - a multi-center case-controlled study. Thromb Haemost. 2004;92:707-713.
25. Dahlback B. New molecular insights into the genetics of thrombophilia. Resistance to activated protein C caused by Arg506 to Gln mutation in factor V as a pathogenic risk factor for venous thrombosis. Thromb Haemost. 1995;74:139-148.
26. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJ, Heijer M, Kluijtmans LA, van den Heuvel LP. A candidate genetic risk factor for vascular disease: a common mutation in methy-lenetetrahydrofolate reductase. Nat Genet. 1995;10:111-113.
27. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3' -untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood. 1996;88:3698-3703.
28. Salomon O, Steinberg DM, Zivelin A, Gitel S, Dardik R, Rosenberg N, Berliner S, Inbal A, Many A, Lubetsky A, Varon D, Martinowitz U, Seligsohn U. Single and combined prothrombotic factors in patients with idiopathic venous thromboembolism: prevalence and risk assessment. Arterioscler Thromb Vasc Biol. 1999;19:511-518.
29. Smith RA, Skelton M, Howard M, Levene M. Is thrombophilia a factor in the development of hemiplegic cerebral palsy? Dev Med Child Neurol. 2001;43:724-730.
30. Thorarensen O, Ryan S, Hunter J, Younkin DP. Factor V Leiden mutation: an unrecognized cause of hemiplegic cerebral palsy, neonatal stroke, and placental thrombosis. Ann Neurol. 1997;42:372-375.
31. Hagstrom JN, Walter J, Bluebond-Langner R, Amatniek JC, Manno CS, High KA. Prevalence of the factor V leiden mutation in children and neonates with thromboembolic disease. J Pediatr. 1998;133:777-781.
32. Hogeveen M, Blom HJ, Van Amerongen M, Boogmans B, van Beynum IM, van de Bor M. Hyperhomocysteinemia as risk factor for ischemic and hemorrhagic stroke in newborn infants. J Pediatr. 2002;141:429-431.
33. Curry CJ, Bhullar S, Holmes J, Delozier CD, Roeder ER, Hutchison HT. Risk factors for perinatal arterial stroke: a study of 60 mother-child pairs. Pediatr Neurol. 2007;37:99-107.
34. Kenet G, Sadetzki S, Murad H, Martinowitz U, Rosenberg N, Gitel S, Rechavi G, Inbal A. Factor V Leiden and antiphospholipid antibodies are significant risk factors for ischemic stroke in children. Stroke. 2000;31: 1283-1288.
35. Duran R, Biner B, Dermir M, Celtik C, Karasalihoglu S. Factor V Leiden mutation and other thrombophilia markers in childhood ischemic stroke. Clin Appl Thromb Hemost. 2005;11:83-88.
36. Komitopoulou A, Platokouki H, Kapsimali Z, Pergamtou H, Adamtziki E, Aronis S. Mutations and polymorphisms in genes affecting hemostasis proteins and homocysteine metabolism in children with arterial ischemic stroke. Cerebrovasc Dis. 2006;22:13-20.
37. Demoerloose P, Boehlen F. Inherited thrombophilia in arterial disease: a selective review. Semin Hematol. 2007;44:106-113.
38. Boffa MC, Aurousseau MH, Lachassinne E, Dauphin H, Fain O, Le Toumelin P, Uzan M, Piette JC, Derenn S, Boinot B, Avcin T, Motta M, Faden D, Tincani A. European register of babies born to mothers with antiphospholipid syndrome. Lupus. 2004;13:713-717.
39. Berkun Y, Padeh S, Barash J, Uziel Y, Harel L, Mukamel M, Revel-Vilk S, Kenet G. Antiphospholipid syndrome in children and recurrent thrombosis. Arthritis Rheum. 2006;55:850-855.
40. Boffa MC, Lachassinne E. Infant perinatal thrombosis and antiphospholipid antibodies: a review. Lupus. 2007;16:634-641.